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Estimation of Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal
Concentration (MBC) of Antimicrobial peptides of Saccharomyces boulardii
against Selected Pathogenic Strains
Abstract
Saccharomyces boulardii is used for antimicrobial peptide production and so can be termed as
bacteriocin molecules with probiotic potential. Antimicrobial peptides are extracted from the culture broth
and followed the purification using Sephadex G-50 column. Further, the inhibition activity was determined
against selected microorganisms and inhibition zone against streptococcus pneumoniae was found to be
highest among selected microbes. The fourth fraction of the peptide after purification was shown a 26
mm bacterial inhibition zone determined by agar well diffusion method. SDS-PAGE analysis revealed the
protein band corresponding to 18 kDa was observed. The MBC/MIC study proved that the peptide extract
of S. boulardii has bactericidal activity.
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1. Introduction
Antimicrobial peptides (AMPs) are oligopeptides
with a varying number of amino acids. AMPs are very
active against multidrug resistant gram positive bacteria
and kill them by disrupting membrane integrity via
interaction with negatively charged cell membrane [1,2].
Probiotics are microorganisms that are beneficial to
humans and animals. Probiotics are used in multifarious
subjects and their branches ranging from depression to
autoimmune diseases and are being used as biotherapeutic agent [3]. Probiotics reduce gastrointestinal
disorders, allergies, diarrhea, bacterial vaginal infections, cholesterol levels, necrotizing enterocolitis,
auto-immune diseases and skin ailments. Saccharomyces
boulardii is a probiotic microbe obtained from lychee
fruit and mangosteen fruit and it can be treated as natural
yeast [4]. It is found in yoghurt which is traditionally
taken after meals to relieve constipation, diarrhea and
other abnormalities in bowel moments. It is also found in
other foods like kefir, kamahi, kombucha, miso etc. It can
be used against antibiotic-induced diarrhea and Clostridium difficile infections [5]. The supplement of probiotic S. boulardii along with antibiotics is used to reduce
diarrhea and stomach pain in patients suffering from
amoeba-related infections. It can also help in treating
lactose intolerance, vaginal yeast infections, canker sores
irritable bowel syndrome (IBS), crohn's disease etc. [6].
S. boulardii synthesizes the inhibition factors such as,
polyamines, alkaline phosphomonoesterases, protease
serine enzyme and short-chain fatty acids. The probiotics
has numerous attributes namely: production of shortchain fatty acids, immunomodulation, bile-salt metabolism and epithelial barrier maintenance which makes
them viable for the extraction of antimicrobial peptides.
Antimicrobial peptides (AMPs) are increasingly coming
into the focus as a new treatment strategies for bacterial
infections [7]. Only a few reports are available on the
antimicrobial peptides of probiotics and hence the present study is aimed to extract the peptides from S. boulardii and then its potency is screened for antimicrobial
activity against selected pathogenic microorganisms.

and pure culture was developed on MRS agar plates. S.
boulardii was inoculated in yeast extract peptone
dextrose medium and incubated at 37  C for 48 h. The
cells were removed by centrifugation at 13,000 RPM for
20 Min., and supernatant was collected separately and
then filtered using 0.45 mm membrane, followed by
dialysis (10e12 kDa). The dialyzed crude extract was
lyophilized. For purification of the antimicrobial peptides, lyophilized crude sample was applied on sephadex
G-50 column. The fractions were collected at regular
intervals using 0.1 M phosphate buffer and absorption
values were recorded at 280 nm. The antimicrobial
peptides present in lyophilized and purified fractions
were separated by SDS-PAGE (12%) analysis [8].
2.2. Proteolytic activity
The proteolytic activity of antimicrobial peptides
was confirmed by treating with protease. The cell free
supernatant is mixed with enzyme at concentration
1.0 mg/mL and then incubated at room temperature for
1 h. After incubation, the antimicrobial activity was
evaluated by well diffusion assay using selected indicator organisms. The cell free supernatant without the
enzyme was kept as a control [9].
2.3. Antimicrobial activity
The antimicrobial activity of extracted peptides was
determined by agar well diffusion assay. Wells were
created aseptically on sabouraud dextrose agar (SDA)
for determining antifungal activity and Mueller-Hinton
agar (MHA) for antibacterial activity respectively,
crude and partially purified antimicrobial extracts were
added to the wells from 1 to 10 mg/ml (w/v) concentrations. The fungal and bacterial cultures were inoculated and then the plates were incubated at room
temperature for 48 and 24 h, respectively. Chloramphenicol (10 mg/mL) and sterile distilled water were
used as positive and negative controls [10]. Antimicrobial compound activity was measured in terms of
both MIC (Minimum inhibitory concentration) and
MBC (Minimum bactericidal concentration).

2. Materials and methods
2.1. Antimicrobial peptides from S. boulardii

2.4. Minimum inhibitory concentration (MIC) and
minimum bactericidal concentration (MBC)

S. boulardii was isolated from probiotic product Gnorm using MRS broth medium by enrichment method

Agar well diffusion method was carried out for MIC
determination. Wells were created aseptically on
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Sabouraud Dextrose Agar (SDA) for determining
antifungal activity and Muller-Hinton agar (NA) for
antibacterial activity was used in the study. The crude
and partially purified antimicrobial protein extracts
were added to the wells in the concentration rages from
10 to 100 mg/mL (w/v). Fungal and bacterial cultures
were inoculated and incubated at 30  C in different
time intervals i.e., 48 h for fungal and 24 h for bacterial
strains respectively. Chloramphenicol (10 mg/mL) and
distilled water were used as positive and negative
controls. The clear zone around well is indicated as
zone of inhibition and the diameter was measured.
For MBC, the broth micro dilution assay was performed by serially diluting the 96-well micro titer plate
with extracted peptide fraction and then the plate is
inoculated with test strains followed by incubation at
30  C for 48 h and 24 h respectively. Bacterial growth
was estimated by measuring the absorbance at 660 nm
using microtiter plate reader. The wells showing >90%
inhibition were taken into consideration by transferring
5 ml of the contents onto a nutrient agar plates followed
by the incubation at similar conditions. The least
concentration with no revival was considered as MBC.
Known antibiotics were taken as control. Further,
MBC/MIC is also calculated to determine the bacteriocidal effect of peptide extract.
Statistical analysis ANOVA analysis and Turkey's
post hoc methods were used to analyze the data
normalization. P-values less than 0.05 are considered
significant. The Standard errors of the mean values
were conveniently represented as ± symbol and the
obtained results with standard error of the mean were
tabulated.
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3. Results and discussion
3.1. Partial purification of antimicrobial peptides
from S.boulardii
Antimicrobial peptides extracted from S. boulardii
were purified and each of the active fractions was
screened for the antimicrobial activity against selected
microbes. Probiotic yeast has attracted the interest of
scientists to work on in recent years and the probiotic
microbes are used to explore antimicrobial properties.
The cell free supernatant of probiotic yeast contains the
antimicrobial peptides is purified by dialysis and gel
permeation chromatography. The fractions are
collected from the chromatography column and the
total concentration of protein in each fraction was
estimated. The SDS-PAGE analysis revealed that the
fraction-4 containing antimicrobial peptide obtained
after purification process from the extract of S. boulardii has shown good inhibition activity against
selected bacteria and fungi. The protein concentration
in each the fraction has shown in Fig. 1 and highest
concentration was found to be 79 mg/mL in fraction-4.
The molecular weight of the purified peptide fraction
was found to be 18 kDa. Crude extract was shown
various protein bands and disappeared after purification (Fig. 2). The concentration of total proteins in
crude and purified samples was shown in Table 1.
3.2. MIC and MBC
The antimicrobial activity of peptides extracted
from S. boulardii was tested against different bacterial

Fig. 1. Elution profile of antimicrobial proteins on Sephadex G-50 column chromatography.
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reported that the peptides from Paenibacillus alvei
AN5 strain showed zone of inhibition 21 mm with
MIC 64 mg/ml against Staphylococcus aureus [11].
The peptide extracted from S. boulardii showed highest
antimicrobial activity (26 ± 0.71 mm) with 40 mg/ml
compared to findings of Alkotaini et al. (2013). Peptide
fraction showed significant antimicrobial activity
against K. pneumoniae, P. Vulgaris, P. aeruginosa, H.
pylori, B. cereus, S. aureus and inhibitory activity was
not found against Asperigillus niger and minimal effect
was found against Candida albicans. The MICs of
extracted peptide ranging from 10 to 250 mg/mL obtained after susceptibility tests represented good antimicrobial activity against the tested pathogens. MBCs
of peptide clearly indicated bactericidal effect against
pathogens especially on S. aureus. The effect of peptide extract on selected indicator organisms has showed
the bactericidal activity. The zone of inhibition values
was found to be low for A. tumefaciens and C. albicans
at 500 mg/ml and 100 mg/ml respectively. The antibiotic chloramphenicol is used standard and its effect
for MIC and MBC against the selected pathogens was
also studied and the findings of the study were included
in Table 2. In previous studies, AL-Saadi et al., 2016
reported that the cell-free extracts of Bifidobacterium
species are effective against the methicillin-resistant
Staphylococcus aureus [12]. The MBC/MIC 2 and
MBC/MIC 4 implies the bactericidal and bacteriostatic effect respectively [13]. Further, ratio of MBC/
MIC is calculated and the concentration of MBC/MIC
is  2 for peptide extract of S. boulardii against the
indicator organisms which indicates that the extract has
bactericidal activity.

Fig. 2. The molecular weight of antimicrobial peptides determined
by SDS-PAGE method compared with standard proteins (Lane Mmarker; Lane 1&2- crude cell free extract; Lane 3- purified band at
18 kDa (fraction-4).

Table 1
Total protein concentration of peptide fractions from S.boulardii.
Volume (ml)

Sample

Total Protein (mg/L)

20
20

Dialyzed Crude
Sephadex G-50

167 ± 3.1
79 ± 2.9

and fungal strains in terms of MIC and MBC respectively. The cell free supernatant when treated with
protease enzyme found no zone of inhibition against
selected indicator organisms which indicates that the
peptide is proteinaceous in nature. Results have shown
that the highest activity was recorded against staphylococcus aureus (26 mm zone). The previous studies

Table 2
MIC and MBC analysis for the antimicrobial peptide fraction of S. boulardii and chloramphenicol.
Name
indicator
organisms

Antimicrobial
activity
(MIC-Zone of
inhibition
(100 mg/ml)

Concentration
of peptide in
mg/mL
for MIC

CFS treated
with
Protease
enzyme

Concentration
of peptide
in mg/mL
for MBC
(mg/mL)

Chloramphenicol
(10 mg/ml)

K. pneumoniae
P. vulgaris
P. aeruginosa
H. pylori
A. tumefaciens
B. cereus
S. aureus
A. niger
C. albicans

20 ±
22 ±
18 ±
16 ±
04 ±
20 ±
26 ±
ND
08 ±

10
25
20
30
250
10
40
ND
70

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

20
50
40
60
500
15
70
ND
100

24
22
24
26
20
18
26
12
16

1.21
1.16
0.85
0.21
0.08
0.65
0.71
0.21

±
±
±
±
±
±
±
±
±

0.25
1.12
0.78
0.56
1.12
0.45
1.16
0.44
0.32

MIC with
Chloramphenicol
(mg/mL)

MBC with
Chloramphenicol
(mg/mL)

3
2
2
3
20
8
1
80
50

5
4
4
5
40
16
2
100
100
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4. Conclusion
The extracted peptide from S.boulardii confirmed
the antimicrobial activities against pathogenic strains.
The peptide has shown high bactericidal effect against
S. aureus. Therefore, the extracts from S. boulardii
could be used source for developing antimicrobial
agents.
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